Assessment of Depression and Anxiety in Chronic Obstructive Pulmonary Disease Patients attending Pulmonary Medicine Department of Rohilkhand Medical College & Hospital, Bareilly, Uttar Pradesh, India
Citation Information :
Kumar A, Jaiswal A, Sharma CS, Rathi H, Arya V. Assessment of Depression and Anxiety in Chronic Obstructive Pulmonary Disease Patients attending Pulmonary Medicine Department of Rohilkhand Medical College & Hospital, Bareilly, Uttar Pradesh, India. Int J Adv Integ Med Sci 2017; 2 (3):137-139.
Chronic disease like chronic obstructive pulmonary disease (COPD) is associated with various comorbidities. Anxiety and depression are among the common comorbidities and have significant impact on socioeconomic status of the person as well as the course of disease. In our study, we screened COPD patients attending the outpatient department (OPD) of pulmonary medicine for anxiety and depression, using different scales that include questionnaires. About 46.2 and 34.6% cases were found to have depression and anxiety respectively, among all COPD patients (n = 156). Incidence of anxiety and depression was directly proportional to severity of disease. Age, gender, locality, educational, marital, and socioeconomic statuses are some factors that play important roles in the development of these psychiatric comorbidities. Hence, mental assessment of COPD patients should be mandatory with every visit to the OPD.
How to cite this article
Jaiswal A, Kumar A, Rathi H, Sharma CS, Sharma P, Arya V. Assessment of Depression and Anxiety in Chronic Obstructive Pulmonary Disease Patients attending Pulmonary Medicine Department of Rohilkhand Medical College & Hospital, Bareilly, Uttar Pradesh, India. Int J Adv Integ Med Sci 2017;2(3):137-139.
A randomized controlled trail of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003 Aug;84(8):1154-1157.
Health status: what does it mean for payers and patients? Proc Am Thorac Soc 2006 May;3(3):222-226.
Prevalence of co-morbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001 Mar;54(3):287-293.
Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med 1994 Apr; 149(4 Pt 1):930-934.
Depression, anxiety and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res 2012 Feb; 14(2):176-183.
Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005 Apr;127(4):1205-1211.
Anxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment. Psychosom Med 2003 Nov-Dec;65(6):963-970.
Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry 2010 Dec;25(12):1209-1221.
The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 Jun;67(6):361-370.
Manual of the beck depression inventory. San Antonio: Psychological Corporation; 1993.
The assessment of anxiety status by rating. Br J Med Psychol 1959;32(1):50-55.
Available from: http://www.goldcopd.com .
Assessment of anxiety and depression in COPD patients—a pilot study. Curr Neurobiol 2012;3(2):112-116.
Prevalence of depression and anxiety in outpatients with chronic airway lung disease. Korean J Intern Med 2010 Mar;25(1):51-57.
Anxiety and depression in COPD—current understanding, unanswered questions and research needs. Chest 2008 Oct:134(4 Suppl):43S-56S.
Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 2008 Nov;23(11):1757-1762.
